Search research articles
Contact Us
Filters
Showing results (201-210 of 687) with videos related to
Page
of 69
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
Susan Stienen, Patrick Rossignol, António Barros, et al.
International Journal of Cardiology
|
April 18, 2009
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial
Bertram Pitt, Faiez Zannad, Mihai Gheorghiade, et al.
American Journal of Hypertension
|
June 1, 2005
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women
Richard A Preston, William B White, Bertram Pitt, et al.
Journal of Cardiac Failure
|
May 19, 2025
Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design
João Pedro Ferreira, Pedro Marques, Ana Rita Leite, et al.
American Heart Journal
|
December 12, 2017
Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trials
Matthias Bossard, Yasser Binbraik, Farzin Beygui, et al.
American Journal of Hypertension
|
December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction
Patrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
European Heart Journal
|
March 3, 2020
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial
Michael Böhm, João Pedro Ferreira, Felix Mahfoud, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 19, 2009
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension
Nathaniel Reichek, Richard B Devereux, Ricardo A Rocha, et al.
Cardiovascular Drugs and Therapy
|
June 28, 2002
Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure
Henry A Glick, Sean M Orzol, Joseph F Tooley, et al.
European Heart Journal
|
January 7, 2011
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt, Stefan D Anker, David A Bushinsky, et al.
Page
of 69
Search research articles
Search
Showing results (201-210 of 687) with videos related to
Sort By:
Page
of 69
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
Susan Stienen, Patrick Rossignol, António Barros, et al.
International Journal of Cardiology
|
April 18, 2009
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial
Bertram Pitt, Faiez Zannad, Mihai Gheorghiade, et al.
American Journal of Hypertension
|
June 1, 2005
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women
Richard A Preston, William B White, Bertram Pitt, et al.
Journal of Cardiac Failure
|
May 19, 2025
Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design
João Pedro Ferreira, Pedro Marques, Ana Rita Leite, et al.
American Heart Journal
|
December 12, 2017
Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trials
Matthias Bossard, Yasser Binbraik, Farzin Beygui, et al.
American Journal of Hypertension
|
December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction
Patrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
European Heart Journal
|
March 3, 2020
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial
Michael Böhm, João Pedro Ferreira, Felix Mahfoud, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 19, 2009
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension
Nathaniel Reichek, Richard B Devereux, Ricardo A Rocha, et al.
Cardiovascular Drugs and Therapy
|
June 28, 2002
Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure
Henry A Glick, Sean M Orzol, Joseph F Tooley, et al.
European Heart Journal
|
January 7, 2011
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt, Stefan D Anker, David A Bushinsky, et al.
Page
of 69